T1	Outcomes 590 650	improve survival and reduce local recurrences and metastases
T2	Outcomes 708 721	survival rate
T3	Outcomes 857 912	lengths of disease-free status and survival of patients
T4	Outcomes 1107 1126	highly advantageous
T5	Outcomes 1270 1282	no advantage
T6	Outcomes 1316 1346	occurrence of lung metastases.
